Zacks Investment Research on MSN
JNJ gets EU nod for expanded use of Akeega in prostate cancer
J&J JNJ announced that the European Commission has approved its precision therapy, Akeega (niraparib and abiraterone acetate dual action tablet), for expanded use in prostate cancer. The regulatory ...
Exhaustion creeps in. Appetite vanishes. Hair thins. The person in the mirror looks gaunt. It's the paradox of cancer treatment: The same drugs meant to save a life can also wear the body down. Nick ...
The FDA announced a new approved use for the drug leucovorin, which Trump has touted as a treatment for autism. But the ...
As obesity rates continue to rise, so do pharmaceutical company investments in novel treatments. By some estimates, there were more than 160 obesity drugs in development in 2025, covering 68 ...
Did you take part in the race this year? Tell us all about your 2007 Great North Run experiences here. If you were a runner in the 2007 Great North Run and want to share your experiences with others, ...
Background Gut bacteria have been implicated in a wide range of health conditions, yet their potential role in preventing and treating muscle-wasting disorders remains largely unexplored. Objective We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results